USPTO Examiner GILLIGAN CHRISTOPHER L - Art Unit 3683

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18902532Artificial Intelligence (AI) to create a patient visit note based on a conversation between a doctor and a patientSeptember 2024March 2025Allow510YesNo
18823175ARTIFICIAL INTELLIGENCE (AI) TO PROVIDE DECISION SUPPORT INSIGHTS INCLUDING WHILE A DOCTOR IS ENGAGED IN CONVERSATION WITH A PATIENTSeptember 2024February 2025Allow510YesNo
18143851ENHANCING PATIENT REFERRAL OUTCOME THROUGH STRUCTURING DATA FOR EFFICIENT PLACE OF SERVICE UTILIZATION RATE ANALYSISMay 2023March 2025Allow2210NoNo
18191534SYSTEMS AND METHODS FOR A HEALTH CARE E-COMMERCE MARKETPLACEMarch 2023March 2025Allow2310YesNo
18188007SYSTEM AND METHOD FOR SOFTWARE AND HARDWARE ACTIVATION BASED ON REAL-TIME HEALTH PARAMETERSMarch 2023August 2024Allow1740NoNo
18169372HEALTH CARE INFORMATION SYSTEM PROVIDING STANDARDIZED OUTCOME SCORES ACROSS PATIENTSFebruary 2023September 2024Allow1910NoNo
18109681System and method for underwriting and financing of elective health procedures for clinical capacity optimizationFebruary 2023April 2025Abandon2610NoNo
18102642KNOWLEDGE BASED MULTI-CRITERIA OPTIMIZATION FOR RADIOTHERAPY TREATMENT PLANNINGJanuary 2023September 2024Allow1910NoNo
18006683TECHNIQUES FOR PROCESSING WIRELESSLY BROADCAST PACKETS FROM A MEDICAL DEVICE WITH DOSE-RELATED DATAJanuary 2023August 2024Allow1940NoNo
17993772Method for machine-assisted automated continuation of conversations between the user, software system, and health expert.November 2022May 2025Abandon3010NoNo
17984914PERSONALIZED HEALTH CONTENT FOR USERSNovember 2022June 2025Allow3120YesNo
17983207Fertility/Reproductive Health System, Protocols, And Methods For Assisting Fertility/Reproductive HealthNovember 2022March 2025Abandon2810NoNo
18051630METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS FOR EVENT CORRELATION AND TRACKING IN A MULTI-STAKEHOLDER ENVIRONMENTNovember 2022November 2024Allow2510YesNo
17907396SYSTEM FOR DELIVERING TARGETED CONTENT TO UNIQUE USER PERSONA GROUPSSeptember 2022April 2025Abandon3110NoNo
17902468SERVER APPARATUS, NETWORK SYSTEM, INFORMATION PROVISION METHOD, AND RECORDING MEDIUMSeptember 2022October 2024Allow2610YesNo
17700379Applying non-real time and non-user attended algorithms to the stored non-imaging data and existing imaging data to obtain a dental diagnosisMarch 2022April 2025Abandon3711NoNo
17700411Applying non-real time and non-user attended algorithms to the stored non-imaging data and existing imaging data to obtain a dental diagnosisMarch 2022May 2025Abandon3820NoNo
17677319DRUG ALTERNATIVE RECOMMENDATION ENGINE FOR REAL-TIME PRESCRIPTION BENEFIT REQUESTSFebruary 2022November 2024Allow3320YesNo
17587578SYSTEM FOR MAINTAINING DRUG INFORMATION AND COMMUNICATING WITH MEDICATION DELIVERY DEVICESJanuary 2022November 2024Abandon3330NoNo
17571968SYSTEM AND METHOD FOR UTILIZING DIGITAL FORENSICS, ARTIFICIAL INTELLIGENCE, AND MACHINE LEARNING MODELS TO PREVENT SUICIDAL BEHAVIORJanuary 2022March 2025Abandon3820YesNo
17440274METHOD AND SYSTEM FOR IDENTIFYING SUBJECTS WHO ARE POTENTIALLY IMPACTED BY A MEDICAL CONDITIONSeptember 2021August 2024Allow3520NoNo
17412038SYSTEMS, APPARATUS, AND METHODS FOR MUSCULOSKELETAL ERGONOMIC IMPROVEMENTAugust 2021January 2025Abandon4120YesNo
17373280HEALTHCARE DATA SYSTEMJuly 2021August 2024Allow3720NoNo
17314166DIAGNOSIS ASSISTANCE DEVICE, DIAGNOSIS ASSISTANCE METHOD, AND RECORDING MEDIUMMay 2021June 2024Allow3820YesNo
17243392System for Reviewing Patient Data from Remote Patient Monitoring DevicesApril 2021February 2025Abandon4521NoNo
17277863A DATA PROCESSING SYSTEM FOR DETECTING HEALTH RISKS AND CAUSING TREATMENT RESPONSIVE TO THE DETECTIONMarch 2021April 2025Allow4920NoNo
17156300SITUATION ADAPTABLE SURGICAL INSTRUMENT CONTROLJanuary 2021April 2025Allow5121YesNo
17156499Method to Create Digital Twins and use the Same for Causal AssociationsJanuary 2021November 2024Abandon4610NoNo
17080094Messaging System For Initiating Event Based WorkflowOctober 2020November 2024Allow4940YesNo
16945018SLEEP SUFFICIENCY ESTIMATION DEVICE AND SLEEP SUFFICIENCY ESTIMATION METHODJuly 2020October 2024Abandon5020NoNo
16604317HOLISTIC PATIENT RADIOLOGY VIEWEROctober 2019June 2025Abandon6060NoYes
14079823DEVICES, SYSTEMS, AND METHODS FOR AUTOMATED MEDICAL PRODUCT OR SERVICE DELIVERYNovember 2013December 2018Allow6051YesNo
13955026SYSTEMS, COMPUTER PROGRAMS, AND METHODS FOR CONTROLLING COSTS OF A HEALTHCARE PRACTICEJuly 2013March 2014Allow710NoNo
13863396METHOD AND A SYSTEM FOR PROVIDING HOSTED SERVICES BASED ON A GENERALIZED MODEL OF A HEALTH/WELLNESS PROGRAMApril 2013December 2017Allow5631YesNo
13858562Device and Method for Automatic Data Acquisition and/or DetectionApril 2013January 2014Allow920YesNo
13841072SYSTEM AND METHOD FOR PROVIDING REAL-TIME BI-DIRECTIONAL CHARGE CAPTURE-CENTRALIZED CONVERSATION BETWEEN BILLING AND PROVIDER ENTITIESMarch 2013April 2019Allow6081YesNo
13783982Personal Business Service System and MethodMarch 2013May 2018Allow6060NoYes
13778028HEALTH MANAGEMENT SYSTEM USING HOME NETWORK AND OPERATION METHOD THEREOFFebruary 2013September 2018Allow6061YesNo
13473725Methods For Delivering A Drug To A Patient While Preventing The Exposure Of A Foetus Or Other Contraindicated Individual to the DrugMay 2012July 2013Allow1410NoNo
13400026DEVICE AND METHOD FOR AUTOMATIC DATA ACQUISITION AND/OR DETECTIONFebruary 2012January 2013Allow1110NoNo
13317546Substance allocation system and method for ingestible product preparation system and methodOctober 2011January 2015Allow3920YesNo
13199545Reporting system and method for ingestible product preparation system and methodAugust 2011September 2015Allow4840YesNo
13199544Reporting system and method for ingestible product preparation system and methodAugust 2011September 2018Allow6080YesNo
13069623METHOD AND SYSTEM FOR FORECASTING CLINICAL PATHWAYS AND RESOURCE REQUIREMENTSMarch 2011March 2014Allow3610NoNo
12966240METHODS FOR DELIVERING A DRUG TO A PATIENT WHILE PREVENTING THE EXPOSURE OF A FOETUS OR OTHER CONTRAINDICATED INDIVIDUAL TO THE DRUGDecember 2010February 2012Allow1410NoNo
12871050PATIENT BED SEARCH AND MANAGEMENT SYSTEMAugust 2010May 2012Allow2110NoNo
12840969CLOUD-BASED HEALTHCARE INFORMATION EXCHANGEJuly 2010April 2013Allow3220YesNo
12821344Interventional roadmap method with optimization of the mask phaseJune 2010September 2013Allow3910NoNo
12788242HEALTHCARE QUALITY MEASUREMENTMay 2010June 2013Allow3720NoNo
12679970DETECTION AND TRACKING OF INTERVENTIONAL TOOLSMay 2010May 2014Allow4920NoNo
12767908METHOD OF COMPENSATION OF RESPIRATORY MOTION IN CARDIAC IMAGINGApril 2010May 2016Allow6050NoNo
12672509Apparatus and method for remote assessment and therapy management in medical devices via interface systemsFebruary 2010May 2014Allow5120YesNo
12700322METHOD, APPARATUS AND SYSTEM FOR COMMUNICATING HEATLHCARE INFORMATION TO AND FROM A PORTABLE, HAND-HELD DEVICEFebruary 2010March 2013Allow3740YesNo
12605280ITERATIVE PROCESSINGOctober 2009May 2013Allow4320YesNo
12468778METHOD AND APPARATUS FOR MONITORING A PATIENTMay 2009February 2012Allow3220NoNo
12249407ERGONOMICS-BASED HEALTH FACILITATOR FOR COMPUTER USERSOctober 2008May 2011Allow3110NoNo
12118768PROCESS, KNOWLEDGE, AND INTELLIGENCE MANAGEMENT THROUGH INTEGRATED MEDICAL MANAGEMENT SYSTEM FOR BETTER HEALTH OUTCOMES, UTILIZATION COST REDUCTION AND PROVIDER REWARD PROGRAMSMay 2008April 2011Allow3510YesNo
12104242CONSISTENCY MODELING OF HEALTHCARE CLAIMS TO DETECT FRAUD AND ABUSEApril 2008September 2013Allow6041NoNo
12036285PATIENT MONITORINGFebruary 2008April 2013Allow6050YesNo
12033760INTEGRATION OF LIFEOTYPES WITH DEVICES AND SYSTEMSFebruary 2008May 2012Allow5030NoNo
12031664DEVICE AND METHOD FOR AUTOMATIC DATA ACQUISITION AND/OR DETECTIONFebruary 2008October 2011Allow4430YesNo
12010707QUALITY ASSURANCE SCORECARD FOR DIAGNOSTIC MEDICAL AGENT ADMINISTRATIONJanuary 2008February 2011Allow3710YesNo
12018740METHOD AND SYSTEM FOR AGGREGATING AND STANDARDIZING HEALTHCARE QUALITY MEASURESJanuary 2008August 2010Allow3010NoNo
11817330METHOD FOR REMOTELY MONITORING BIOLOGICAL DATAAugust 2007February 2011Allow4220NoNo
11725360MEDICAL MONITORING SYSTEMMarch 2007September 2011Allow5411NoNo
11699350METHOD AND APPARATUS FOR GENERATING AN ADMINISTRATIVE QUALITY ASSURANCE SCORECARDJanuary 2007July 2010Allow4210NoNo
11483444NETWORKED SYSTEM FOR INTERACTIVE COMMUNICATION AND REMOTE MONITORING OF INDIVIDUALSJuly 2006March 2011Allow5710YesNo
11004135USER MONITORINGDecember 2004December 2010Allow6010NoNo
10431630ITERNET-BASED, CUSTOMIZABLE CLINICAL INFORMATION SYSTEMMay 2003June 2007Allow5030YesNo
10360858CONSISTENCY MODELING OF HEALTHCARE CLAIMS TO DETECT FRAUD AND ABUSEFebruary 2003February 2008Abandon6011YesNo
10208466METHOD FOR SELECTIVELY ENABLING OR BLOCKING THE USE OF MEDICAL EQUIPMENTJuly 2002November 2007Allow6020NoNo
10142310APPARATUS, DEVICE AND METHOD FOR PRESCRIBING, ADMINISTERING AND MONITORING A TREATMENT REGIMEN FOR A PATIENTMay 2002November 2007Allow6030YesNo
10084326METHOD AND SYSTEM FOR ENHANCED MEDICAL TRIAGEFebruary 2002November 2007Allow6011NoNo
09681311INTEGRATION OF RADIOLOGY INFORMATION INTO AN APPLICATION SERVICE PROVIDER DICOM IMAGE ARCHIVE AND/OR WEB BASED VIEWERMarch 2001March 2008Allow6060NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GILLIGAN, CHRISTOPHER L.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
16.6%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
2
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
2
(100.0%)
Filing Benefit Percentile
8.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner GILLIGAN, CHRISTOPHER L - Prosecution Strategy Guide

Executive Summary

Examiner GILLIGAN, CHRISTOPHER L works in Art Unit 3683 and has examined 72 patent applications in our dataset. With an allowance rate of 80.6%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 39 months.

Allowance Patterns

Examiner GILLIGAN, CHRISTOPHER L's allowance rate of 80.6% places them in the 44% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by GILLIGAN, CHRISTOPHER L receive 2.36 office actions before reaching final disposition. This places the examiner in the 81% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by GILLIGAN, CHRISTOPHER L is 39 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +16.2% benefit to allowance rate for applications examined by GILLIGAN, CHRISTOPHER L. This interview benefit is in the 60% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 27.7% of applications are subsequently allowed. This success rate is in the 39% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 29.4% of cases where such amendments are filed. This entry rate is in the 34% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 18% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 15% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 25.0% are granted (fully or in part). This grant rate is in the 16% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 6.9% of allowed cases (in the 93% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 37% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.